Thursday, February 18, 2016 5:19:00 AM PDT | VentureDeal
Burlingame, California -- Medical device technology company Cala Health has received $18 million in new equity venture capital investment, according to an SEC regulatory filing.
Cala says that it is "developing novel therapies based on recent neuroscience discoveries from Stanford University." Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds. A total of 15 investors participated in the offering. CEO Kate Rosenbluth has been with the firm since January 2014.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
